Language selection

Search

Patent 1098127 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1098127
(21) Application Number: 257701
(54) English Title: 2,6-ANTHRAQUINONYLENE AMIDINES AS ANTI-AMEBIC AGENTS
(54) French Title: 2,6-ANTHRAQUINONYLENE COMME AGENT ANTIAMIBIEN
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/236
(51) International Patent Classification (IPC):
  • C07D 295/20 (2006.01)
  • C07D 211/26 (2006.01)
  • C07D 223/12 (2006.01)
  • C07D 295/195 (2006.01)
(72) Inventors :
  • LANG, STANLEY A., JR. (United States of America)
  • FABIO, PAUL F. (United States of America)
  • LIN, YANG-I. (United States of America)
  • MURDOCK, KEITH C. (United States of America)
  • FIELDS, THOMAS L. (United States of America)
(73) Owners :
  • AMERICAN CYANAMID COMPANY (United States of America)
(71) Applicants :
(74) Agent: SMART & BIGGAR
(74) Associate agent:
(45) Issued: 1981-03-24
(22) Filed Date: 1976-08-12
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
606,805 United States of America 1975-08-22

Abstracts

English Abstract






TITLE: 2,6 ANTHRAQUINONYLENE AMIDINES
AS ANTI-AMEBIC AGENTS




ABSTRACT OF THE DISCLOSURE
Novel 2,6 anthraquinonylene amidines that are
effective against cecal and hepatic amebic infestations in
warm-blooded animals.


Claims

Note: Claims are shown in the official language in which they were submitted.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method of preparing a 2,6-anthroquinonylamidine
of the formula

(I)
Image

wherein R1 is hydrogen, alkyl, branched alkyl, cycloalkyl (C1-C15)
heterocyclic phenyl or substituted phenyl; and R2 and R3 are
each hydrogen, phenyl, substituted phenyl, alkyl or branched
alkyl, or R2 and R3 taken together with the nitrogen atom to
which they are attached form a heterocyclic ring, and pharma-
ceutically acceptable salts thereof, which comprises
(a) reacting 2,6-diaminoanthraquinone with a complex
formed by mixing phosphorous oxychloride and an N,N-dialkylamide
or N-alkylamide in an inert solvent at a temperature of about
25° to 70°C for a period of about 1 to 24 hours;
(b) reacting 2,6-diaminoanthraquinone with a 2-
methoxy-1-cycloalkene in a dimethylacetamide or dimethylformamide
at a reflux temperature for a period of about 1 to 12 hours;
(c) refluxing 2,6-diaminoanthraquinone with triethyl
ortho acid and acetic anhydride for a period of about 1 to 8
hours;
(d) combining diethyl N,N'-(2,6-anthraquinonylene)-
di-formimidate with a primary or secondary amine and heating at
a temperature of about 130°-200°C for about 2 to 18 hours;

(e) combining diaminoanthraquinone with dialkylamide
dialkylacetal and heating at about 130°C-10°C for about 2-66


32


hours; or
(f) combining diaminoanthraquinone with an amide and
an aryl sulfonyl halide and heated at about 90°C for about 2-3
hours, and, if necessary
(g) converting a free base product to a pharmaceut-
ically acceptable salt or vice versa.


2. A 2,6-anthraquinonylamidine of formula I as defined
in claim 1 or a pharmaceutically acceptable salt thereof, when-
ever prepared by the method of claim 1, or by an obvious chemical
equivalent thereof.


3. A method of preparing N',N'"-2,6-anthraquinonylenebis-
[N,N-dimethyl formamidine], which comprises heating 2,6-diamino-
anthraquinone with N,N-dimethylformamide diethyl acetal.


4. N',N'"-2,6-Anthraquinonylenebis[N,N-dimethyl form-
amidine], whenever prepared by the method of claim 3, or by an
obvious chemical equivalent thereof.


5. A method of preparing N',N'"-(2,6-anthraquinonylene)
bis-N,N-diethyl acetamidine, which comprises reacting 2,6-di-
aminoanthraquinone with the complex formed by mixing phosphorous
oxychloride and N,N-diethylacetamide.


6. N',N'"-(2,6-Anthraquinonylene)bis-N,N-diethyl acet-
amidine, whenever prepared by the method of claim 5, or by an

obvious chemical equivalent thereof.


7. A method of preparing N',N'"-(2,6-anthraquinonylene)-
bis-N,N-diisopropyl formamidine, which comprises heating
together 2,6-diaminoanthraquinone, diisopropylformamide and
p-toluenesulfonyl chloride.


33


8. N',N'"-(2,6-Anthraquinonylene)bis-N,N-diisopropyl
formamidine, whenever prepared by the method of claim 7, or by
an obvious chemical equivalent thereof.


9. A method of preparing 2,6-bis-(piperidinomethylene-
amino)anthraquinone, which comprises heating together N,N'-
(2,6-anthraquinonylene)-di-formimidic acid diethyl ester and
piperidine.


10. 2,6-Bis-(piperidinomethyleneamino)anthraquinone,
whenever prepared by the method of claim 9, or by an obvious
chemical equivalent thereof.


11. A method of preparing N',N'"-(2,6-anthraquinonylene)-
bis(N,N-dimethyl)acetamidine, which comprises heating together
2,6-diaminoanthraquinone, N,N-dimethylacetamide and p-toluene-
sulfonyl chloride.


12. N',N'"-(2,6-Anthraquinonylene)bis(N,N-dimethyl)-
acetamidine, whenever prepared by the method of claim 11, or by
an obvious chemical equivalent thereof.


13. A method of preparing 2,6-bis[(1-piperidinopropyli-
dene)amino]anthraquinone, which comprises heating together N,N'-
(2,6-anthraquinonylenedipropionimidic acid diethyl ester and
piperidine.



14. 2,6-Bis[(1-piperidinopropylidene)amino]anthraquinone,
whenever prepared by the method of claim 13, or by an obvious
chemical equivalent thereof.


15. A method of preparing 2,6-bis[(1-piperidinoethyl-
idene)amino]anthraquinone, which comprises heating together
N,N'-2,6-anthraquinonylenediacetimidic acid diethyl ester and
piperidine.


34


16. 2,6-Bis[(1-piperidinoethylidene)amino]anthraquinone,
whenever prepared by the method of claim 15, or by an obvious
chemical equivalent thereof.


17. A method of preparing 2,6-bis[(1-morpholinoethylid-
ene)amino]anthraquinone, which comprises refluxing 2,6-diamino-
anthraquinone, triethylorthoacetate and acetic anhydride to form
N,N'-2,6-anthraquinonylenediacetimidic acid diethyl ether, and
reacting this product with morpholine.


18. 2,6-Bis[(1-morpholinoethylidene)amino]anthraquinone,
whenever prepared by the method of claim 17, or by an obvious
chemical equivalent thereof.


19. A method of preparing 2,6-bis[(1-morpholinopropyl-
idene)amino]anthraquinone, which comprises reacting N,N'-2,6-
anthraquinonylenedipropionic acid diethyl ester with morpholine.


20. 2,6-Bis[(1-morpholinopropylidene)amino]anthraquinone,
whenever prepared by the method of claim 19, or by an obvious
chemical equivalent thereof.


21. A method of preparing 2,6-bis[1-(4-methylpiperidino)-
ethylidene]amino anthraquinone, which comprises reacting N,N'-
2,6-anthraquinonylenediacetimidic acid diethyl ether with 4-
methylpiperidine.



22. 2,6-Bis[1-(4-methylpiperidino)ethylidene]amino
anthraquinone, whenever prepared by the method of claim 21, or
by an obvious chemical equivalent thereof.


23. A method of preparing N',N"'-2,6-anthraquinonylene-
bis[N-isopropyl acetamidine], which comprises reacting 2,6-di-
aminoanthraquinone, phosphorous oxychloride and N-isopropyl
acetamide.





24. N',N'"-2,6-Anthraquinonylenebis[N-isopropyl acetamid-
ine], whenever prepared by the method of claim 23, or by an
obvious chemical equivalent thereof.


25. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N-methyl acetamidine], which comprises reacting N-methyl
acetamide, 2,6-diaminoanthraquinone and phosphorous oxychloride.


26. N',N'"-2,6-Anthraquinonylenebis[N-methyl acetamid-
ine], whenever prepared by the method of claim 25, or by an
obvious chemical equivalent thereof.


27. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-diethyl cyclopropanecarboxamidine], which comprises
reacting N,N-diethyl cyclopropanecarboxamide, phosphorous oxy-
chloride and 2,6-diaminoanthraquinone.


28. N',N'"-2,6-Anthraquinonylenebis[N,N-diethyl cyclo-
propanecarboxamidine], whenever prepared by the method of
claim 27, or by an obvious chemical equivalent thereof.


29. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-dimethyl cyclobutanecarboxamidine], which comprises
reacting N,N-dimethyl cyclobutanecarboxylic acid amide with
phosphorous oxychloride and then adding 2,6-diaminoanthraquinone.



30. N',N'"-2,6-Anthraquinonylenebis[N,N-dimethyl cyclo-
butanecarboxamidine], whenever prepared by the method of claim
29, or by an obvious chemical equivalent thereof.


31. A method of preparing 2,6-bis[(1-methyl-2-pyrrolidin-
ylidene)amino]anthraquinone, which comprises reacting 1-methyl-
2-pyrrolidinone with phosphorous oxychloride and then adding
2,6-diaminoanthraquinone.


36


32. 2,6-Bis[(1-methyl-2-pyrrolidinylidene)amino]anthra-
quinone, whenever prepared by the method of claim 31, or by an
obvious chemical equivalent thereof.


33. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-diethyl acetamidine]-4,4'-methylenebis[3-hydroxy-2-
naphthoate], which comprises reacting N',N'"-2,6-anthraquinonyl-
ene bis[N,N-diethyl acetamidine] with pamoic acid.


34. N',N'"-2,6-Anthraquinonylenebis[N,N-diethyl acetamid-
ine]-4,4'-methylenebis[3-hydroxy-2-naphthoate], whenever pre-
pared by the method of claim 33, or by an obvious chemical
equivalent thereof.


35. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-dimethyl cyclopropanecarboxamidine], which comprises
reacting together N,N-dimethyl cyclopropanecarboxamide, 2,6-
diaminoanthraquinone and phosphorous oxychloride.


36. N',N'"-2,6-Anthraquinonylenebis[N,N-dimethyl cyclo-
propanecarboxamidine], whenever prepared by the method of claim
35, or by an obvious chemical equivalent thereof.


37. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N,2-trimethylpropionamidine], which comprises reacting
N,N,2-trimethylpropionamide with phosphorous oxychloride and
then adding 2,6-diaminoanthraquinone.



38. N',N'"-2,6-Anthraquinonylenebis[N,N,2-trimethyl-
propionamidine], whenever prepared by the method of claim 37,
or by an obvious chemical equivalent thereof.


39. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N-ethyl acetamidine], which comprises reacting N-ethyl-
acetamide with phosphorous oxychloride and then adding 2,6-di-



37


aminoanthraquinone.


40. N',N'"-2,6-Anthraquinonylenebis[N-ethyl acetamidine],
whenever prepared by the method of claim 39, or by an obvious
chemical equivalent thereof.


41. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-diethyl acetamidine] succinate, which comprises reacting
N',N'"-2,6-anthraquinonylenebis(N,N-diethyl)acetamidine with
succinic acid.


42. N',N'"-2,6-Anthraquinonylenebis[N,N-diethyl aceta-
midine] succinate, whenever prepared by the method of claim 41,
or by an obvious chemical equivalent thereof.


43. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-diethyl acetamidine]dihydrochloride, which comprises
reacting N',N'"-2,6-anthraquinonylenebis-N,N-diethyl acetamidine
with hydrochloric acid.


44. N',N'"-2,6-Anthraquinonylenebis[N,N-diethyl acetamid-
ine]dihydrochloride, whenever prepared by the method of claim
43, or by an obvious chemical equivalent thereof.


45. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-dimethyl propionamidine], which comprises reacting N,N-
dimethylpropionamide with phosphorous oxychloride and then adding
2,6-diaminoanthraquinone.


46. N',N'"-2,6-Anthraquinonylenebis[N,N-dimethyl propion-
amidine], whenever prepared by the method of claim 45, or by an
obvious chemical equivalent thereof.


47. A method of preparing N',N'"-2,6-anthraquinonylene-
bis[N,N-dimethyl-p-chlorobenzamidine], which comprises reacting


38


N,N-dimethyl-p-chlorobenzamide with phosphorous oxychloride and
then adding 2,6-diaminoanthraquinone.


48. N',N'"-2,6-Anthraquinonylenebis[N,N-dimethyl-p-
chlorobenzamidine], whenever prepared by the method of claim
47, or by an obvious chemical equivalent thereof.


39

Description

Note: Descriptions are shown in the official language in which they were submitted.


9B127
,; .
United States Patent No. 3,184,482 discloses a com- ~
pound of the formula: ~ ;
/ 1
O N=CH-N ^~
R4 î~



wherein Rl and R2 are hydrogen or lower alkyl and R3, R4 and R5
are hydrogen, hydroxy or
~Rl :
-N=CHN \
R2




Utility is described as antibacterial, antiviral, antiprotazoal
and anthelmintic.
This invention is concerned with novel compounds of
the formula

R~ r ~ c/ R2 (1)




wherein Rl is selected from the group consisting of hydrogen,
alkyl, branched alkyl, cycloalkyl (Cl-C15), heterocyclic, phenyl
and substituted phenyl; and R2 and R3 are each hydrogen, phenyl,
substituted phenyl, alkyl or branched alkyl, or R2 and R3 taken
- 1 - ~


. . . .
... ~ , ~ ,. ....

~9~3~27

together with the nitrogen atom to which they are attached form
a heterocyclic ring, and pharmaceutically acceptable salts
thereof; the method of treating cecal and hepatic amebic
infections in warm-blooded animals with said compounds; and
their method of preparation.
The compounds of the present invention are normally
crystalline solids being soluble in dimethylformamide and di-
methylsulfoxide and less soluble in chlorGform, alcohol and




.; .
., .




- la -

~`

27

acetone. The salts (mono and di) are readily soluble ln water
and less soluble in alcoholO
The compounds of the present invention may be pre-
pared according to the following methods:
A) 2,6-Diaminoanthraquinone (1 mole) is reacted with a com-
plex formed from phosphorous oxychloride-(1.5 to 3 moles) and
an N,N-dialkylamide or N-alkylamide (2 to 6 or more moles) in
a solvent such as acetonitrile (at a ratio of about 1-3 liters
of solvent per mole of amine) at a temperature of 25 to 70C
for a period of about one to 24 hours.
More specifically, to a solution of the N,N-dialkyl-
amide or N-alkylamide in the solvent is added phosphorous
oxychloride at -5 to 20C. The resulting mixture is stirred
at 0 to room temperature for 30 minutes to 6 hours. The 2,6-

-diaminoanthraquinone is added and the reaction mixture is
stirred at 25 to 70C for one to 24 hours. The reaction
mixture is then poured into ice water and basified. The re-
sulting crystals are collected by filtration and recyrstallized
from an appropriate solvent or mixture of solvents such as
chloroform/hexane.
B) 2,6-Diaminoanthraquinone (1 mole) lS reacted with a l-aza-
2-methoxy-1-cycloalkene (2 to 5 or more moles) in a solvent
such as dimethylacetamide or dimethylformamide at a ratio of
about one liter of solvent per mole of amine and acetic acid
at a ratio of about 2 moles per mole of amine at reflux tem-
perature for a period of one to 12 hours. The addition of
ether to the reaction mixture causes the precipitation of the
product which is collected and recrystallized as in (A).
C) 2,6-Diaminoanthraquinone (72 parts) is slurried in 3nO
parts of a triethyl ortho acid and 250 parts of acetic anhyd-

ride is added. The mixture is refluxed for one to 8 hours,
cooled and the solid product is collected, washed and dried.

- Purification is accomplished by dissolving this crude product
-- 2

.~9~3~Z7

in 1000 parts of chloroform, filtration and concentration of
t:he filtrate. Further purification may be realized by re-
crystallization from a solvent such as dimethylformamide. A
bis-imino-ether (8 parts) is slurried in 45 parts of an appro-

priate amine. One equivalent of glacial acetic acid for eachpart of iminc-ether is added and the slurry is heated in an
oil bath at 100-160C for 8 to 24 hours. (The use of a
bomb is recommended with low boiling amines.) The reaction
mixture is cooled. Products which crystallize are collected
; 10 and recrystallized from a solvent such as methanol, ethanol,
methyl cellosolve or dimethylformamide. For products which
do not crystallize, the volatiles are removed ln vacuo and
the residue is dissolved in methanol. Upon cooling the product
crystallizes and is recrystallized from a suitable solvent
as abové.
D) Diethyl N,N'-(2,6-anthraquinonylene) di-formimidate is
combined with at least 2 molar equivalents of a primary or
secondary amine and heated at a temperature of 130-200C
for 2 to 18 hours. The reaction mixture is stripped of vola-
tiles under reduced pressure and the pure product is obtained
by recrystallization from a suitable solvent.
E) Diaminoanthraquinone is combined with 2 or more molar
equivalents of dialkylamide dialkylacetal with or without the
corresponding amide as solvent. The mixture is heated at
130-150C for 2 to 66 hours. The reaction mixture is strip-
ped of volatiles under reduced pressure. The residue is washed
with hexane and the product is obtained by recrystallization
from a suitable solvent.
F) Diaminoanthraquinone is combined with 2 or more molar
equivalents of an amide. To this mixture is added at least
2 equivalents of an aryl sulfonyl halide. The mixture is

heated at below 100C for 2 to 3 hours. Alcohol is added to
the reaction mixture. The insoluble salt is collected and
-- 3

~81Z7

treated with an aqueous base to obtain the free base. Re-
crystallization from a suitable solvent gives the purified
product.
The compounds of the present invention are active
in treating cecal and hepatic amebic infections in warm-blooded
animals. Two tests which establish this activity are as
follows:
Organism

.
The organism used in both tests is the National
Institute of Health 200u strain of Entamoeba histolytica.
This strain and an unidentified fecal flora are cultured in
Cleveland-Collier~Medium at 37C. This medium consists of a
liver infusior. agar base overlaid with a horse serum:saline
mixture (1:6) to which is added a few milligrams of sterile
rice powder. The amebas are transferred to fresh medium twice
weekly.
Cecal Infections in Female Albino Wistar Rats
Pooled overlay (0.25 ml) containing large numbers
Of amebas is injected into the cecums of anesthetized weanling
rats during laparotomy. Treatment is begun on the day after
inoculation. The compounds are dissolved or suspended in 0.2~
- aqueous agar and administered once daily, by gavage, for 5 con-
secutive days. 5ix days after inoculation of the amebas, the
rats are sacrificed and a scraping from the cecal wall of each
rat is mixed with a drop of 0.85% saline and examined micro-
scopically for amebas. A rat is considered cured if no amebas
are seen. The cure or clearance rate (number cured/number
treated) for each regimen is calculated and corrected for non-
specific curçs observed in the untreated infected controls.
An active dose is the lowest dose, in terms of mg/kg/day,

which clears or cures 50% or more of the rats so treated.
The results of typical compounds of the present invention
` appear in the following table together with results obtained
-- 4
.

~98~Z7


using known effective drugs for comparison.
Hepatic Infections in Female Golden Hamsters
A piece of ameba-laden absorbable sponge, about 25
millimeters square, is inserted between the middle lobes of
the livers of anesthetized hamsters during laparotomy. Un-
treated hamsters usually die from the resulting infection
about 7 days after inoculation. Treatment is started on the
day of inoculation as soon as the hamsters recover from the
surgical anesthetic. The test compounds are dissolved or sus-

pended in 0.2%-aqueous agar and admlnistered once daily, by
gavage, for 5 ccnsecutive days. Effective regimens prevent
mortality. Survival rates are corrected for non-specific
survival observed in untreated groups. An active dose is
the lowest dose, expressed in mg/kg/day, which protects 50%
or more of the hamsters so treated as evidenced by survival
14 days after inoculation. The results of typical compounds
of the present invention appear in the following table to-
gether with the active dose of known effective drugs for com-
parison.


' ' .
!




- 5 -

31Z7
.




_ a)
H O . .
c~ a) ~ . .
~ ~ . ~,
H , ~ O ~ I O O I I I U~ O O U~
o ~ ~ o o ~ ~ o ~
H ~ ~ . ~ ~ .
~: ~ . .
~ 3 .
~C ~
_ ~ . ' . I
OH a . I
E~ ~ ~
'~ ~ O o O O O O O O O . O O U~
H ~ ~ ~ ~1 Ut ~ ~ U~
~4 o
a) t~ 3 .
O ~ ..
~r _

~q ~o
u~
. 'Q 'Q 'Q Q O ~ I
~ 1 o o
a) a) a~ N ,1
.
'?~ ~ ~ ~ ~1 ~Q~ ~ h ~ ~ a
C ~.~ C ~ . C ~ ~ o s
. . o ~ o ~o ~ o ~ o
. ~n~ c ~ ~ ~ S ~ a~
~ ~ ~ o o~ s o.
Z ~ C
' ~ C~ ~ ~ rl~ O
o ~ o o ~ C ~ ~ s ~
P~ S ~S td S ~ ~ S IH ,~ ~ C ~ C
~ o ~ a
o ~ S ~ a
.I ~ I I . a)~ o aJ ~ a x
~1 ~ ~1 ~D E3~D h ~ O I ~ 1 ~ O I ~rl
. ~ ~I S~I S ~ ~ H 0 1-) N

. N ~ N S N Z N O Q~
U~ ~ O N
m ~ m o m o m
z I z I æ u z I I s
~z ~æ ~ o ~z
-
_ z æ _ z z z zz z N ~ N ~ N (d N (lI ~ Q~ N Z E-~
_ _ ,

.
,

-- 6 --

::

~9131Z7

The novel 2,6 anthraquinenylene amidines of the
present invention are useful for ameliorating cecal and
hepatic amebic infections in warm-blooded animals when ad-
ministered in amounts ranging from about 0.5 mg. per kg. to
about 40 mg. per kg. of body weight per day. A preferred
dosage regimen for optimum results would be from about 2 mg.
per kg. to about 29 mg. per kg. Thus, the daily dosage em-
ployed for a subject of about 70 kg. of body weight is about
35 mg. to about 2.8 g., and preferably about 140 mg. to about
2.0 g.
- Suitable oral preparations consist, for example, of
capsules, tablets, troches, suspensions, syrups and the like.
In the case of tablets the principal active ingredient is
mixed with conventional ingredients such as corn starch, lac-
tose, sucrose, sorbitol, talc, stearic acid, magnesium stear-
ate, dicalcium phosphate, gums or similar materials as non-
toxic pharmaceutically acceptable diluents or carriers.
Sustained release formulations are also contemplated
by the present invention.
The liquid forms in which the novel compositions of
the present invéntion may be incorporated for administration
include suitably flavored emulsions with edible oils, such as,
cottonseed oil, sesame oil, coconut oil, peanut oil and the
like, as well as elixirs and similar pharmaceutical vehicles.
Sterile suspensions or solutions can be prepared for parenteral
use. Isotonic preparations containing suitable preservatives
are also desirable for in]ectable use.
Example 1
N,N'-(2,6-Anthraquinonylene)-di-formimidic acid
diethyl ester
A 35.7 g portion of 2,6-diaminoanthraquinone is
mixed with 100 ml of triethylorthoformate containing 5 drops
of concentrated H2SO4. The mixture is heated to reflux and
-- 7 _

~9~Z7
,
the alcohol is removed as it forms over a 2 hour period. The
reactlon mixture is cooled to -10C, the solid which forms is
col]ected by filtration, washed with 2B alcohol and air dried.
~ecrystallization from dimethylformamide produces brown crys-
tals, mp 235-250C.
Example 2
2,6-Bis[(4-methyl-1-piperazinylmethylene)amino]-
anthraquinone
A 5.25 g portion of N,N'-(2,6-anthraquinonylene)-
di-formimidic acid diethyl ester, 4.0 ml of N-methyl pipera-
zine and 100 ml of dimethylformamide are heated together on a
steam bath overnight. The mixture is cooled, filtered and the
solid is washed with dimethylformamide and 2B alcohol and
dried ln vacuo at 78C over P2O5 producing an oranye solid,
mp 278-281C.
Example 3
N',N"'-(2,6-Anthraquinonylene)bis-N,N-dimethyl formamidine
A suspension of 7.15 g of 2,6-diaminoanthraquinone
in 17.68 g of N,N-dimethylformamide diethyl acetal is stirred
and heated in an oil bath at 150C for 17 hours. The by-
product, ethanol, distills out. A 30 ml portion of dimethyl-
formamide is added and the hot mixture is filtered. The solid
is washed with acetone giving red-brown rods. These rods are
recrystallized from 30 ml of dimethylformamide and dried 4
hours at 80C giving a pale yellow solid.
Example 4
N',N"'-(2,6~Anthraquinonylene)bis-N,N-diethyl formamidine
A 5.95 g portion of 2,6-diaminoanthraquinone and
14.7 g of diethylformamide dimethyl acetal [prepared as de-
scribed by H. Bredereck et al., Chem. Ber. 101, 41-50 (1968)]
are combined and refluxed for 66 hours at 150C in an oil bath.
The reflux condenser is removed and the distillate is allowed
to boil off. The remaining volatiles are removed ln vacuo.
-- 8 --

- ~639~3~L27

The residue is slurried with 50 ml of hexane, filtered and
the solid is washed with hexane and air dried. This solid is
extracted with 2 x 100 ml of boiling methanol, fil-tered while
hot, the filtrate is cooled to -10C producing a solid which
is recovered by filtration and dried ln vacuo over P2O5. This
solid is recrystallized from 200 ml of boiling methyl cello-
solve, cooled to -10C, filtered and the red solid is dried
in vacuo over P2O5, mp 182-184C.
Example 5
N',N"'-(2,6-Anthraquinonylene)bis-N,N-dibutyl formamidine
A 50 ml portion of N,N-dibutylformamide and 5.95 g
of 2,6-diaminoanthraquinone are combined and 16.9 g of _-
toLuene sulfonyl chloride is added. The mixture is heated on
a steam bath for 2 1/2 hours. A 150 ml portion of 2B alcohol
is added, the mixture is heated to boiling and filtered while
hot. The filtrate is c0012d to -10C and a brown solid is
recovered and dried at 78~C in vacuo over P2Os. This solid is
dissolved in 300 ml of hot water and 20 ml of lN NaOH is added.
The solid which forms is recrystallized from 150 ml of metha-
nol (cooled to -10C) and dried at 78C Ln vacuo over P2O5
giving an orange solid, mp 98-100C.
- Example 6
N',N"'-(2,6-Anthraquinonylene)bis-N,N-diethyl acetamidine
To a solution of 276.0 g of dried N,N-diethylacet-
amide in 800 ml of acetonitrile, which is cooled in an ice-
water bath to 5-10C, is added dropwise 87.4 ml of phosphorous
oxychloride over a period of 10 to 15 minutes. The ice-water
balh is removed and the resulting mixture is stirred at room
temperature for one hour. A 95.2 g portion of 2,6-diamino-
anthraquinone is added and the resulting mixture is stirred
without heating for one hour and then at 60~C for 7 1/2
hours. The mixture is cooled to room temperature and is poured
into 1000 ml of ice-water. The aqueous solution is diluted
g

. . .

~98~Z7

to 3000 ml and is made basic with 5_ sodium hydroxide. The
orange-yellow crystals formed are collected by filtration,
then the material is washed with water and air dried. The
product is dissolved in 450 ml of chloroform, is filtered and
is precipitated out with about 400 ml of hexane to give the
flnal product as orange crystals, mp 173-175C.
Example 7
N',N"'-(2,6-Anthraquinonylene)bis-N,N~ropyl formamidine
A 95.3 g portion of 2,6-diaminoanthraquinone, 260 ml
of triethyl orthoformate and 6 drops of concentrated H2SO4 are
combined and heated in an Gil bath for 2 hours so that the
ethanol is distilled off. A 140 ml portion of triethyl ortho-
formate is added and heating at 140C is continued in an oil
bath for 6 hours. The mixture is cooled in an ice bath and
filtered. The solid is washed twice with ether, dried at 64C
overnight and then at 78C in vacuo over P2O5 giving a brown
solid. A 10 g portion of this solid and 50 ml of di-n-propyl-
amine are combined and heated with stirring in an oil bath at
140C for 90 minutes. The mixture is allowed to cool overnight
and the volatiles are removed in vacuo. The brown solid is
recrystallized from 400 ml of 2B alcohol giving an orange
solid. This solid is recrystallized from 200 ml of methyl
cellosolve (cooled to -10C) giving an orange solid, mp 182-
185C.
Example 8
N',N"'-(2,6-Anthraquinonylene)bis-N-octyl-N-
methyl formamidine
A 10.0 g portion of N,N'-(2,6-anthraquinonylene)-
di-formimidic acid diethyl ester and 13.3 g of N-methyl oct-
ylamine are combined and heated in an oil bath at 150C for
90 minutes. ~he mixture is cooled and the volatile component
is removed ln vacuo. The residue is slurried with two 50 ml
portions of hexane, filtered and the orange solid is air dried.
~ 10 --

~g~:~Z7

This product is recrystalllzed from a hot mixture of 100 ml of
benzene and 200 ml of hexane. Cooling the mixture at 4C
gives the product which is dried at 78C in vacuo over P2O5
yielding an orange solid, mp 81-83C.
Example 9
N',N"'-(2,6-Anthraquinonylene)bis-N,N-diisopropyl formamidine
A 5.95 g portion of 2,6-diaminoanthraquinone and
10.0 g of dlisopropylformamide are combined to form a slurry.
To this slurry is added 14.3 g of p-toluenesulfonyl chloride.
The mixture is heated on a steam bath for 2 1/2 hours. A
100 ml portion of 2B alcohol is added and the mixture is re-
fluxed for 5 minutes. The mixture is heated to boiling and
the solid is recovered by filtration, washed with 2B alcohol
and air dried. This solid is slurried in 150 ml of hot water,
filtered while hot and the insoluble solid is washed twice
with water. The filtrate and washes are treated with excess
10N NaOH to pH 10. The orange precipitate is washed twice
with water and air dried. This-solid is recrystallized from
150 ml of 2B alcohol (cooled to -10C) and dried at 78C ln
vacuo over P2O5 giving an orange solid, mp 206-208C.
.
- Example 10-
N',N"'-(2,6-Anthraquinonylene)bis[N~(p-chlorophenyl)]
formamidine
A 10.0 g portion of N,N'-(2,6-anthraquinonylene)-
-di-formimidic acid diethyl ester and 7.66 g of p-chloroaniline
are combined and heated in an oil bath at 160C for 7 hours
and then allowed to stand at room temperature. The solid
residue is recrystallized from 350 ml of dimethylformamide
(cooled to -10C) and dried at 78C in vacuo over P2O5 giving
a red solid.

~ 31Z7

Example 11
N',N"!-(2,6-Anthraquinonylene)bis(N-methyl-N-phenyl)
formamidine
A 10.0 g portion of N,N'-(2,6-anthraquinonylene)-

di-formimidic acid diethyl ester and 25 ml of N methylaniline
are heated at 140C for 2 hours in an oil bath and then allow-
ed to stand at room temperature overnight~ The reaction mix-
ture is triturated with two 50 ml portions of hexane and air
dried. The orange-brown solid is recrystallized from 200 ml
of dimethylformamide cooled to 4C. The solid is recovered
by filtration, washed with dimethylformamide and twice with
2B alcohol and dried at 78C ln vacuo over P2O5 giving a
dark orange solid, mp 308-312C.
Example 12
2,6-Bis(piperidinomethyleneamino)anthraquinone
A mixture of 7.0 g of N,N'-(2,6-anthraquinonylene)-
di-formimidic acid diethyl ester and 7.48 g of piperidine is
heated in an oil bath at 130-140C for 2 hours and then allow-
ed to stand at room temperature overnight. The reaction mix-
ture is triturated with two 50 ml portions of hexane and the
brown solid is air dried. This solid is recrystallized from
275 ml of boiling methyl cellosolve which is filtered whlle
hot and then cooled to 4C. The solid is washed with methyl
cellosolve and with 2B alcohol and dried at 78C ln vacuo
over P2O5 gi~lng an orange solid, mp 229-233C.
Example 13
N,N'-2,6-Anthraquinonylenedi-acetimidic acid diethyl ester
A mixture of 35.7 g of 2,6-diaminoanthraquinone,
lOO ml of triethylorthoacetate and 6 drops of concentrated
- 30 sulfuric acid is heated for 6 hours in an oil bath at 130C

with a take-off condenser and four inch Vigreux Column. A
5 ml portion of ethyl alcohol is collected, then the mixture
is allowed to stir at room temperature overnight. An addi-
- 12 -

~9~Z7

tional 60 ml of triethylorthoacetate is added, the mixture is
refluxed for 6 hours longer and is allowed to stir overnight
at room temperature. The brownish solid collected by filtra-
tion is washed with e-ther and dried ln vacuc. A 10 g portion
of the above product is recrystallized from 400 ml of methyl
cellosolve, the solid is filtered and washed twice with ether
and is dried in vacuo at 50C to give orange-tan crystals.
A 1.0 g portion of the brownish solid previously
described is recrystallized from 100 ml of dimethylforma~lide
to give orange crystals after drying ln vacuo at 50C. The
recrystallized materials are combined to give the final pro-
duct, mp 195-197C.
Example 14
N',N"'-2,6-Anthraquinonylenebis(N-1,1,3,3-tetra-
methylbutyl) formamidine
A 95.3 g portion of 2,6-diaminoanthraquinone, 260 ml
of triethylorthoformate and 6 drops of concentrated sulfuric
acid is combined in a one liter round bottom flask which is
fitted with a short Vigreux Column fused to a takeoff con-

denser. The flask is heated to reflux in an oil bath so thatethyl alcohol is distilled off. After 2 hours a total of
35 ml of-ethyl alcohol is collected, then 140 ml of triethyl-
orthoformate is added to the thickened reaction mixture and
heating is continued in an oil bath at 140C. Approximately
lOQ ml of distillate is collected over about a 6 hour period
at about 80C. The column is then removed and replaced by a
takeoff condenser and heating of the oil bath is continued
to 165C. An additional 15 ml of distillate is collected at
140C. The flask is removed from the oil bath, cooled in an
ice bath and is filtered. The solid is washed twice with
ether, pressed dry and dried in a ventilated oven at 64C

overnight. Drying is continued ln vacuo at 78C over phos-
phorous pentoxide to give a brown solid, mp 233-280C, iden-
- 13 -



~L~39~3~Z7

tified as N,N'-(2,6-anthraquinonylene)-di-formimidic acid
diethyl ester.
A slurry of 10 g of the preceding compound and 20 ml
of tertiary octylamine in an open flask is heated in an oil
bath at 170C. The mixture thickens in about 10 minutes and
is mixed periodically with a spatula. A liquid with a boiling
point of about 80C is distilled off over a 2 hour period.
The heat is turned off and the mixture is allowed to cool in
the oil bath overnlght. The reaction mixture is then slur-

ried with hexane and is filtered, this step is repeated andthe dark orange solid is air dried. The product is then
extracted with three 1~0 ml portions of boiling benzene and
after drying is recrystallized from 100 ml of methyl cellosolve
to give an orange-yellow solid, mp 195-198C.
Example 15
2,6-Bis~[1-(4-methyl-1-piperazinyl)ethylidene]-
amino}-anthraquinon_
A mixture of 7.5 g of N,N'-2,6-anthraquinonylenedi-
acetimidic acid diethyl ester and 40 ml of _-methyl piperizine
is heated in an oil bath at 145C with a reflux condenser
for 24 hours. The condenser is removed and the mixture is
heated for an additional 30 minutes. Upon cooling to room
temperature a solid mass is formed which is diluted with 100 ml
of diethyl ether and is filtered to gi-~e a tannish solid which
is washed with diethyl ether and dried in vacuo. The dried
material is recrystallized from 85 ml of dimethyl formamidé
to give yellowish crystals. The product is dried in vacuo at
80C.-

Example 16
N',N"'-(2,6-Anthraquinonylene)bis(N,N-dimethyl)acetamidine

To a mixture of 5.96 g of 2,6-diaminoanthraquinone
and 20 ml of N,N-dimethylacetamide is added 14.3 g of _-toluene
sulfonyl chloride. The material is then heated on a steam
- 14 -


~,- . .

~9~
bath for 2 hours with a color change from red to brown. A
100 ml portion of 2B ethyl alcohol is added, the solution is
heated to bolling and filtered. The filtrate is cooled at
-10C. The solid collected is then washed with 2B alcohol.
The solid is slurried in hot water, filtered while hot, and
the insoluble solids washed twice with hot water. The f iltrate
and washes are basified with NaOH. The orange solid is dried,
recrystallized from 2B alcohol and dried at 78C under vacuum
with P2O5, mp 295-330C.
- Example 17
N,N'-2,6-Anthraquinonylenedi-prop onimidic acid
diethyl ester
A mixture of 7.2 g of 2,6-diaminoanthraquinone,
30 ml of triethylortho propionate and 25 ml of acetic anhydride
is refluxed for 2 hours. The mixture is cooled to room tem-
perature and a solid is collected by filtration then is washed
with diethyl ether and dried ln vacuo. Thé product is recry-
stallized from dimethyl formamide to give orange crystals,
mp 195-198C.
Example 18
2,6-Bis~[l-(4-methyl-1-piperazinyl)propylidene]-
amino~-anthraquinone
.
A mixture of 8.12 g of N,N'-2,6-anthraquinonylenedi-
propionimidic acid diethyl ester and 40 ml of N-methylpiper-
azine is heated in an oil bath at about 140C with a reflux
condenser for 20 hours. The condenser is removed and the mix-
ture is heated an additional hour, then is concentrated to a
thick brown syrup ln vacuo. The syrup is stirred with 125 ml
of diethyl ether and the orange brown solid is collected by
filtration, washed with ether and dried ln vacuo. The dried
material is rècrystallized from 70 ml of dimethylformamide -
to give dark yellow crystals, mp 208-210C.

.
- 15 -

~L~98~27

Example 19
2,6-Bis[(l-pi~eridinopropylidene)amino]anthraquinone
A mixture of 8.12 g of N,N'-2,6-anthraquinonylenedi-
propionimidic acid diethyl ester and 40 ml of piperidine is
S heated in an oil bath at 115C with a reflux condenser for
18 hours. The condenser is removed and the mixture is heated
an additional hour, then is concentrated in vacuo to a brown
syrup. The syrup is then stirred with 100 ml of diethyl ether
resulting in a brown solid which is filtered and washed with
ether, then dried in vacuo; The dried product is recrystal-
lizea from 40 ml of dimethylformamide to give dark yellow
crystals,'mp 183-185C.
Example 20
2,6-Bis[(l-piperidinoethylidene)amino]anthraquinone
A mixture of 7.56 g of N,N'-2,6-anthraquinonylenedi-
acetimidic acid diethyl ester and 40 ml of piperidine is heated
in an oil bath at 120C, with a reflux condenser for 20 hours.
The condenser is removed and the mixture heated an additional
hour, then is concentrated in vacuo to a dark syrup. The
syrup is triturated with 100 ml of diethyl ether, the resulting
orange solid is collected by filtration, washed with ether
- and is dried ln vacuo. The dried material is recrystallized
from 40 ml of dimethylformamide to give yellow crystals,
mp 233-235C.
Example 21
2,6-Bis ~[4-(3-dimethylaminopropyl)piperidino]-
methylene~amino~ anthraquinone
A suspension of 7.0 g of N,N'-(2,6-anthraquinon-
ylene)-di-formimidic acid diethyl ester and 15.0 g of 4-(3-
dimethylaminopropyl)- piperidine dihydrochloride is heated
in an oil bath at 160C for 3 hours in a flask fitted with a
short Vigreux Column fused to a take-off condenser, during
this time the 78C distillate is allowed to boil off. The
-- 16 --

81~7

reaction mixture is allowed to cool in the oil bath then is
slurried with hexane and filtered. The solid is dissolved
in 100 ml of boiling dimethylformamide and is filtered hot.
I'he resulting filtrate is cooled at -10C and filtered to
obtain an orange solid. This solid is recrystallized from
25 ml of me~hyl cellosolve and is filtered hot to clarify.
The filtrate i's cooled at -10C and the orange solid is col-
lected. The product is then dried in vacuo at 78C over
phosphorous pentoxide to give an orange solid, mp 171-174C.
' Example 22
' 2,6-Bis[(l-morpholinoethylidene)amino]anthraquinone
- A 72 y portion of 2,6-diaminoanthraquinone, 300 ml
of triethylorthoacetate and 250 ml of aGetic anhydride are
refluxed for 3 hours, cooled in an ice bath and the resulting
brownish crystals are collected'by filtration, washed with
etherand dried gi-~ing N~Nl-2l6-anthraquinonylenedi-acetimidic
acid diethyl ester.
A 7.56 g portion of this imino ether and 40 ml of
morpholine are heated in an oil bath at 135C with à reflux
condenser for 18 hours. The mixture is cooled in an ice bath.
The brownish crystals are collected by filtration, washed with
ether and dried in vacuo. These crystals are slurried in
100 ml of dimethylformamide, heated to boiling and filtered.
The filtrate is stirred in a refrigerator for 3 hours and
the yellow-orange crystals are collected by filtration and
dried ln vacuo, mp 285-288C. ' .
Example 23
' 2,6-Bis[(l-morpholinopropylidene)amino]anthraquinone
A mixture of 8.12 g of N,N'-2,6-anthraquinonylenedi-

propionimidic' acid diethyl ester (Example 17) and 40 ml ofmorpholine are heated in an oil bath with a reflux condenser

at 130C for 18 hours. The mixture is then cooled in an ice
bath and the dark yellow solid is collected by filtration,
- 17 -



- ~9~31;Z7

washed with ether and dried in vacuo at 80C, mp 220-223C.
Example 24
2,6-Bis~[l-(4-methylpiperidino)ethylidene]-
amino~anthraquinone
A 7.56 g portion of N,N'-2,6-anthraquinonylenedi-
acetimidic acid diethyl ester and 40 ml of 4-methylpiperidine
are heated in an oil bath at 130C with a reflux condenser
for 18 hours. The mixture is cooled in an ice bath, the
orange solid is collected by filtration, washed with ether
and dried in vacuo at 80C. This solid is recrystallized
from 100 ml of methyl cellosolve and the yellow crystals are
dried ln vacuo at 80C, mp 200-202C.
Example 25
2,6-Bis'~[1-(4-methylpiperidine)propylidene]-
amino}anthraquinone
A mixture of 8.12 g of N,N'-2,6-anthraquinonylenedi-
propionimidic acid diethyl ester and 40 ml of 4-methylpiperi-
dine is heated with a reflux condenser at 130C for 18 hours.
The reaction mixture is cooled in an ice bath and is filtered.
The-filtrate is concentrated in vacuo to a dark
brown gum which is taken up in 50 ml of methyl cellosolve with
heating.- The solution is stored in a freezer for 2 hours.
The product is collected by filtration and is washed with a
small amount of methyl cellosolve then with diethyl ether.
The product is dried in vacuo at 80C to give yellow crystals,
mp 150-153C.
Example 26
-
N',N"'-2,6-Anthraquinonylenebis(N,N-dipropyl)propionamidine
A mixture of 8.12 g of N,N'-2,6-a~thraquinonylenedi-
propionimidic acid diethyl ester, 45 ml of di n-propylamine
and 2.35 ml of glacial acetic acid is heated at 110C in an
oil bath with a reflux condenser for 18 hours. The reaction
mixture is cooled to room temperature and is filtered, the
- 18 -

~L~98~Z7
precipitate is washed with diethyl ether. The combined filtrate
and washings are concentrated ln vacuo to a dark brown syrup
which is taken up in about 50 ml of methyl alcohol and is
stored in a freezer overnight.
The product is collected by filtration and is dried
in vacuo to give orange crystals, mp 125-128C.
Example 27
N',N'ii-2,6-AnthraquinonylenekistN,N-dibutyl)propionamidine
A mixture of 8.12 g of N,N'-2,6-anthraquinonylenedi-
propionimidic acid diethyl ester, 50 ml cf di-n-butylamine and
2.35 ml of glacial acetic acid is heated in an oil bath at
150C for 18 hours. The reaction mixture is cooled in an ice
bath and diluted with an equal volume of diethyl ether. The
resulting reddish-brown solid is collected by filtration,
washed with ether and is dried in vacuo. The dried material
is taken up in about 40 ml of methanol and allowed to stand
in the refrigerator overnight. The solution is filtered and
the orange crystals are dried ln vacuo at 80C. The product
is recrystallized from 30 ml of 2B ethyl alcohol to give
orange crystals, mp 115-117C.
- Example 28
Nl,N"'-2,6-Anthraquinonylenebis(N-butyl-N-methyl)-
.
~; propionamidine
A mixture of 8.12 g of N,N'-2,6-anthraquinonylenedi-
propionimidic acid diethyl ester, 45 ml of N-methyl butylamine
and 2.35 ml of acetic acid is heated at 130C in an oil bath
with a reflux condenser for 18 hours. The reaction mixture
is cooled to room temperature and filtered. The filtrate is
concentrated ln vacuo to a dark brown syrup which is taken up
in 30 ml of methanol and is stored in a freezer. After 2
hours the orange crystals are filtered and washed with a small
amount of methanol and dried ln vacuo. The product is then
recrystallized from 30 ml of methanol to give yellow crystals,
-- 19 --

`
,

1~9~3~Z7

mp 80-82C.
Example 29
2,6~Bis~[(4-methylpiperidino)methylene]amino~anthraquinone
A mixture of 6.8 g of N,N'-(2,6-anthraquinonylene)-
di-formimidic acid diethyl ester and 8.93 g of 4-methylpiperi-
dine is heated in an oil bath at 140C for 2 hours in a flask
fitted with a short Vigreux Column fused to a take-off con-
denser,- during this time the 78C distillate is allowed to
boil off. The reaction mixture is allowed to cool in the oil
bath overnight, then is triturated with two 50 ml portions of
hexane. The rust brown solid is air dried, recrystallized
from 275 ml of boiling methyl cellosolve and filtered hot to
clarify. The filtrate is cooled to 4C and the solid is fil-
tered and washed with methyl cellosolve followed by 2B ethyl
alcohol. The product is dried in vacuo at 78C over phos-
phorous pentoxide to give an orange solid, mp 229-233C.
Example 30
2,6-Bis(4,5,6,7-tetrahydro-3H-azepin-2-ylamino)anthraquinone
A mixture of 11.9 g of 2,6-diaminoanthraquinone,
28.0 g of 1-aza-2-methoxy-1-cycloheptene and 6.0 g of glacial
acetic acid in 50 ml of N,N-dimethylacetamide is heated under
reflux in an oil bath for 2 hours. The mixture is cooled to
room temperature and lOO ml of diethyl ether is added. The
product formed is filtered and is washed copiously with di-
methyl sulfoxide, ethyl alcohol and finally ether to give
greenish-yellow crystals. This material is dissolved in
chloroform and is filtered. The filtrate is evaporated to
about 30 ml and the final product i5 precipitated out with
ether. Filtration and washing with ether gives orange-yellow
crystals, mp 295-298C.



- 20 -


Example 31
N',N"'-2,6-AnthraquinGnylenebis(N,N'-diethyl)-
propionamidine
A 72 g portion of 2,6-diaminoanthraquinone, 300 ml
of triethyl ortho propionate and 250 ml of acetic anhydride
are refluxed for 2 hours and then cooled in an ice bath. The
reddish-brown solid is collected by filtration, washed with
ether and dried. This material is slurried in one liter of
chloroform and filtered. The filtrate is treated with acti-

vated charcoal, filtered and concentrated in vacuo to theorange solid N,N'-2,6-anthraquinonylenedi-proplonimidic acid
diethyl ester.
An 8.12 g portion of the above imino ether, 65 ml
of diethyl amine and 2.35 ml of glacial acetic acid are heated
in a bomb at 125C for 16 hours. The bomb is cooled in an
ice bath and then opened. The reaction mixture is filtered
and the filtrate is concentrated in vacuo to a tacky solid. -~
This solid is taken up in 30 ml of methanol with the aid of
heat and then stored in a freezer for 2 hours. The orange-
yellow crystals which form are collected by filtration,
washed-with a small amount of methanol and dried in vacuo.
Thls material is slurried in 50 ml of m~thanol, heated to
boiling and the insoluble yellow solid is collected by filtra-
tion. This solid is slurried in 50 ml of water and filtered
giving a yellow solid which is dried in vacuo at 8QC,
mp 147-150C.
Examp]e 32
N',N"'-2,6-Anthraquinonylenebis(N-butyl-N-methyl)-
acetamidin_
A mixture of 72 g of 2,6-diaminoanthraquinone,
300 ml of triethyl orthoacetate and 250 ml of acetic anhydride
is refluxed for 3 hours, cooled in an ice bath and the brown

crystals are collected by filtration, washed with ether and

~(~9~3~2~7

dried. This material is slurried in 800 ml of chloroform,
filtered and the filtrate is concentrated ln ~acuo to the
orange solid N,N'-2,6-anthraquinonylenedi-acetimidic acid
diethyl ester.
A 7.56 g portion of the above imino ether, 45 ml
of N-methyl butylamine and 2.35 ml of glacial acetic acid is
heated in an oil bath for 17 hours and then filtered. The
filtrate is evaporated ln vacuo to a brown gum. This gum is
dissolved, with the aid of heat, in 30 ml of methanol and
then stored in-a freezer for 2 hours. The orange crystals
are collected by filtration, washed with methanol, dried and
recrystallized from 30 ml of methanol giving the product as
orange crystals, mp 114-116C.
Example 33
N',N"'-2,6-Anthraquinonylenebis(N,N'-dimethyl)-
propionamidine
To a solution of 24.2 g of N,N-dimethylpropionamide
in 200 ml of acetonitrile, which is cooled in an ice-water
bath to 5-15C is added dropwise 21.6 ml of phosphorous
oxychloride. The resulting mixture is stirred at room tem-
perature for 30 minutes, then 23.8 g of 2,6-diaminoanthra-
quinone is added and stirring is continued at room temperature
for 1~ hours. The mixture is then stirred for 5 hcurs at 60C.
The reaction mixture is poured into one liter of ice-water,
is stlrred and is then filtered through a slntered glass
funnel. The material retained on the funnel is extracted
repeatedly with water and the combined solution of filtrate
and extracts is made basic with 5N sodium hydroxide. The
oran~e cryytals formed are collected by filtration. The
crystalline material is washed with water and air dried. The
product is then recrystallized from methyl cellosolve to give
orange crystals, mp 206-209C.

- 22 -

lC~9~31Z7
.

Example 34
N',N'''-(2,6-Anthraquinonylene)bis-N,N-diethy~
acetamidine dihydrochloride
A portion of N',N"'-(2,6-anthraquinonylene)bis-N,N-
diethyl acetamidine is suspended in methyl alcohol and methan-
olic HCl is added with stirring until solution is achieved,
diethyl ether is added until cloudiness develops. The solution
is kept at 0C overnight then is filtered. The precipitate
collected is the dihydrochloride salt of N',N' -(2,6-anthra-
quinonylene)bis-N,N-diethylacetamidine.
Example 35
2,6-Bis(piperidinomethyleneamino)anthraquinone
dihydrochloride trihydrate
A 6.1 g portion of 2,6-bis(piperidinomethyleneamino)-
anthraquinone, as prepared in Example 12, is slurried in 300 ml
of chloroform and is filtered. To the filtrate ls added 10 ml
of 4.5_ hydrochloric acid in isopropyl alcohol resulting in
formation of a pale orange precipitate which is stored at
-10C then is filtered. The collected product is washed on
the filter with chloroform and is dried at 78C ln vacuo over
phosphorous pentoxide to give a pale orange solid as the tri-
hydrate of the dihydrochloride.
Example 36
., .
;~ N',N"'-2,6-Anthraquinonylenebis(N,N-diethyl)benzamidine
To a solution of 75.2 g of diethylamine in 600 ml
of diethyl ether is added a solution of 56.3 g of benzoyl chlor-
ide in 100 ml of ether. The mixture is stirred at room tem-
perature for 2 hours, then 50 ml of water is added in order
to dissolve any excess amine and amine hydrochloride. The
ether layer is washed with 3 additional portions of water and
then is dried over anhydrous sodium sulfate. The ether is
removed _ vacuo to give N,N-diethylbenzamide as a colorless
oil .
- 23 -

1l;~9131Z7

To a'stirred solution of 23.8 g of the above product
in 200 ml of acetonitrile maintained at 5-10C in an ice-
water bath is added 36.8 g of phosphorous oxychloride. The
ice-water bath is removed and the resulting mixture is stirred
at room temperature for one hour. A 23.8 g portion of 2,6-
diaminoanthraquinone is then added and the mixture is stirred
at 60C for 10 hours. The reaction mixture is then poured
into 600 ml of ice-water and made basic wi-th 5N sodium hydrox-
,ide solution~ The product is formed as orange crystals which
are collected by iltration and are washed with water. The
'product is then recrystallized from chloroform/hexane to give
reddish-orange crystals, mp 243-246C.'
Example 37
2,6-Bis(~-~iperidinobenzylideneamino)anthraquinone
,
,, 15 To a stirred solution of 28.6 g of benzoylpiperidine
in 150 ml of acetonitrile maintained at 5-10C in an ice-
water bath i- added 18.4 g of phosphorous oxychloride. The
, ice-water bath is removed and the resulting mixture is stirred
at room temperature for one hour. A 11.9 g portion of 2,6-
diaminoanthraquinone is then added and the mixture is stirred
' at 60C for 10 hours. The reaction mixture is then poured
- into 500-ml of ice-water and made basic with 5_ sodium hydrox-
,' ' ide solution. The product is formed as orange crystals which
are collected by filtration and are washed with water. The
product is then recrystallized from chloroform/acetone to give
' orange crystals, mp 264-266C.
Example 38
'N',N"'-(2,6-Anthraquinonylene)bis-N-piperidino-N-
.
' _-chlorobenzylidene
To a stirred solution of 33.55 g of _-chlorobenzoyl
piperidine in 100 ml of acetonitrile cooled at 5-15C in an
ice-water bath is added 10.8 ml of phosphorous oxychloride
over a 30 minute perlod. The ice-water bath is removed' and
- 24 -

;:

~9~

stirring is continued at room temperature for 30 minutes, then
11.9 g of 2,6-diaminoanthraquinone is added and stirring is
continued at room temperature for one hour, then at 60C for
~0 hours. The reaction mixture is then cautiously poured
into a mixture of 500 ml of ice-water and stirring is continued
for one hour gradual1y adding 75 ml of lON sodium hydroxide.
The reddish solid is collected by filtration, is washed with
water and is dried in vacuo at 80C. The dried material is
slurried in 300 ~1 of chloroform and is filtered. The filtrate
is washed 4 times with water, is dried over magnesium sulfate,
is filtered and concentrated ln vacuo. The résidue is slur-
ried with 50 ml of methyl alcohol and is filtered to collect
the orange crystals which are washed with diethyl ether. The
product is dried ln v~cuo to give orange crystals, mp 275-
277C.
Example 39
N',~"'-(2,6-Anthraquinonylene)bis-N-diethyl-
N-p-chlorobenzylidine
To a stirred solution of 31.75 g of N,N-diethyl-_-
chlorobenzamide in 100 ml of acetonitrile cooled at 5-15C
in an ice-water bath is added 10.8 ml of phosphorous oxy-
chloride over a 30 minute period. The ice-water bath is re-
moved and stirring is continued at room temperature for 30
minutes, then 11.9 g of 2,6-diaminoanthraquinone is added and
stirring is continued at room temperature for one hour, then
at 60C for 20 hours. The reaction mixture is then cautiously
poured into a mixture of 500 ml of ice-water and stirring is
continued for one hour gradually adding 75 ml of lON sodium
hydroxide. The red solid is collected by filtration, is washed
with water and is dried ln vacuo at 80C. The dried material
is slurried in 300 ml of chloroform and is filtered. The
filtrate is washed 2 times with water, is dried over magnesium
sulfate, is filtered and concentrated in vacuo to a syrup.
- 25 -

1~91~127

This material is slurried with 25 ml of methyl alcohol and
the orange-red crystals formed are collected by filtration.
The product is washed with diethyl ether and is dried in
vacuo, mp 253-255C.
Example 40
N',N"'-2,6-Anthraquinonylenebis[N-isopropyl acetamidine]
To a solution of 99.2 g of isopropylamine in
600 ml of ether is added 60 g of acetyl c~lloride at -10
in a methanol-ice bath. The reaction mixture is kept at
room temperature for 4 hours and then filtered. The fil-
trate is concentrated under reduced pr ssure giving an
oil. This oil is distilled giving N-isopropyl acetamide
as a colorless oil.
A 23.8 g portion of 2,6-diaminoanthraquinone,
36.8 g of pho~phorous oxychloride, 30.3 g o N-isopropyl
acetamide and 200 ml of acetonitrile are reacted as de-
scribed in Example 1 giving the product as orange crystals
mp 264-267C.
Example 41
N',N'"-2,6-Anthraquinonylenebis[N-methyl acetamidine]
A mixture of 21.8 g of N-methyl acetamide,
23.8 g of 2,6-diaminoanthraquinone, 36.8 of phosphorous
oxychloride and 200 ml of acetonitrile are reacted as
described in Example 1 resulting in a brown crude product
as orange crystals, mp 266-269C.
Example 42
N',N"'-2,6-Anthraquinonylenebis~N,N-diethyl acetamidine]
4,4'-methylenebis[3-hydroxy-2-naphthoate -
A 4.326 g portion of N',N"'-2,6-anthraquinony-
lenebis~N,N-diethyl acetamidine] and 3.884 g of pamoic




- 26 -
- -,. . ,:~,, .., . ~ ,.

~9~1~7

acid are dissolved in 20 ml of dimethylformamide and then
filetered. Ether is added causing the product to precipi-
l:ate as yellow crystals of the pamoate salt, mp 253-255C.
~.
N~,N"'-2,6-Anthraquinonylenebis[N,N-dlmethyl cyclopro-
panecarboxamidine
To a solution of 300 ml of 40% aqueous dimethyl-
amine in 500 ml of ether is added 52.0 g of cyclopropane
carboxylic acid chloride in 100 ml of ether dropwise at
10-25C. The mixture is stirred at room temperature for
2 hours. A 50 ml portion of water is added. The ether
layer is separated, washed with three 50 ml portions of
water, dried over Na2SO4 and filtered. The ether is re-
moved and the residue is distilled giving N,N-dimethyl
cyclopropanecarboxamide as a colorles~ oil.
A 34.0 g portion of the above product, 23.8 g
of 2,6-diaminoanthraquinone, 36.8 g of phosphorous oxy-
chloride and 20~ ml of acetonitrile are reacted as de-
scribed in Example 1. Recrystallization from 2-methoxy-
ethanol giVes the product as orange crystals, mp 241-243C.
Example 44
N',N"'-2,6-Anthraquinonylenebis~N,N-diethyl cyclopro-
panecarboxamidine]
A 134 ml portion of' diethylamine in 600 ml of
ether and 52.0 g of cyclopropane carboxylic acid chloride
are reacted as described in Example 45 giving N,N-diethyl-
cyclopropanecarboxamide as a colorless oil.
A 42.4 g portion of the above product, 23.8 g
of 2,6-diaminoanthraquinone, 36.8 g of phosphorous oxy-
chloride and 200 ml of acetonitrile are reacted as de-



- 27 -

~9~3~;27

scribed in Example 1. Recrystallization from 2-methoxy-
ethanol gives the product as orange crystals, mp 166-168C.
Example 45
N',N"'-2,6-Anthraquinonylenebis[N,N-dimethyl cyclobutane-
carboxamidinel
To a solution of 19.1 g of N,N-dimethyl cyclo-
butanecarboxylic acid amide in 150 ml of acetonitrile was
added 18.4 g of phosphorous oxychloride at 5-10C. The
resulting mixture was stirred at room temperature for 1
hour. Then, 11.9 g of 2,6-diaminoanthraquinone was added.
; The mixture was stirred at 60C. for 10 hours, poured into
600 ml of ice-water and then basified with 5N NaOH. Orange
; crystals were collected by filtration and washed with water.The crystals were dissolved in chloroform and filtered.
The chloroform was removed under reduced pressure. Re-
crystallization of the residue from methyl cellosolve gave
16.2 g of orange crystals, mp 209-211C.
Example 46
2,6-Bis[(l-methyl-2-pyrrolidinylidene)amino]anthraquinone
To a solution of 34.5 g of 1-methyl-2-pyrroli-
dinone in 150 ml of CH3CN was added 18.4 g of phosphorous
oxychloride at 5-10C. The mixture was stirred at room
temperature for 1 hour. To the mixture was added 11.9 g
of 2,6-diaminoanthraquinone. The resulting mixture was
stirred at 60C for 10 hours, poured into 1000 ml of ice-
-water and basified with 5N NaOH. Réddish crystals thus
obtained were collected by filtration and washed with
water. Recrystallization from methyl cellusolve gave 14.0
g of reddish crystals, mp 267-269C.




- 28 -

9~31;27 -`

Example 47 r
N',N"'-2,6-Anthraquinonylenebis[N,N,2-trimethyl~ropion-
amldlne
To a solution of 23.3 g of N,~,2-trimethylpropion-
amide in 150 ml of acetonitrite was added 36.8 g of phos-
phorous oxychloride at S-10C. The resulting mixture was
stirred at room temperature for 1 hour. Tl~en 23.8 g of
2,6-diaminoanthraquinone was added. The mixture was stir-
red at 60C. for 10 hours, poured into 600 ml of ice-water
and then basified with 5N NaOH. Orange crystals were col-
lected by filtration and washed with water. The crystals
were dissolved in chloroform and filtered. The chloroform
was removed under reduced pressure. Racrystallization of
the residue from methyl cellusolve gave 8.0 g of orange
crystals, mp 166-168C.
Example 48
N',N"'-2,6-Anthraquinonylenebis[N-ethylacetamidine]
To a solution of 26.1 g of N-ethylacetamide in
200 ml. of acetonitrile was added 36.8 g of phosphorous
oxychloride at 5-10~C. The resulting mixture was stirred
at room temperature for 1 hour. Then, 23.8 g of 2,6-
-diaminoanthraquinone was added. The mixture was stirred
; at 60C for 10 hours, poured into 600 ml of ice-water and
then basified with 5N NaOH. Orange crystals were collected
~y filtration and washed with water. The orange crystals
were dissolved in chloroform and filtered. The chloro-
form was removed under reduced pressure. Final recrystal-
lization from a CHC13/hexane mixture gave 10;5 g of orange
crystals, mp 271-273C.




-- 2g --

:~9~ 7
Example 49
N' N"'-2 6-Anthra uinon lenebis[N,N-dieth l]acetamide
Y Y
succinate
~ 4.33 g portion of N',N"'-2,6-anthraquinony-
lenebis(N,N-diethyl)acetamidine in 100 ml of chloroform
and 1.18 g of succinic acid in 100 ml of methanol were
mixed. The resulting solution was evaporated under re-
duced pressure to dryness. The resulting yield was 5.5 g
of orange crystals mp 165-166C.
Example 50
N',N"~-2,6-Anthraquinonylenebis[N,N-dimethyl-3-dimethyl-
propionamidine
To a solution of 19.4 g of N,N-dimethylpival-
amide in 100 ml of acetonitrile was added 18.4 g of phos-
phorous oxy¢hloride at 5-15C. over a 30 minute period.
The resulting mixture was stirred at room temperature for
30 minute~, and then heated in an oil bath at 60~C for one
hour. Then, 11.9 of 2,6-diaminoanthraquinone was added and
the temperature of the oil bath was raised to 78C for
20 hours. Next, the mixture was poured into 500 ml of ice-
water. The mixture separated into oil and aqueous phases.
The aqueous phase was decanted from the oil and filtered.
The filtrate was basified with 75 ml of 10N NaOH. Consid-
erable solid was precipitated, collected and washed 3 times
with water and dried to result in a product with a melting
point, 158-160C.
Example 51
N',N"'-2,6-Anthraquinonylenebis[N,N-dimethyl-p-chloro-
henzamidine]
To a stirred solution of 27.6 g of N,N-dimethyl-
-




- 30 -

~ass~27

-p-chlorobenzamide in lO0 ml of acetonitrile cooled at
5-15C in an ice-water bath is added 10.8 ml of phosphor-
ous oxychloride over a 30 minute period. The ice-water
bath is removed and stirring is continued at room temper-
ature for 30 minutes, then 11.9 g of 2,6-diaminoanthraquin-
one is added and stirring is continued at room temperature
for one hour, then at 60C for 20 hours. The reaction mix-
ture is then cautiously poured into a mixture of 500 ml
of ice-water and stirring is continued for one hour grad-
ually adding 75 ml of lON sodium hydroxide. The orange
solid is collected by filtration, is washed with water and
is dried in vacuo at 80C. The dried material is slurried
in 300 ml of chloroform and is filtered. The filtrate is
wa~hed 2 time8 wlth water, i~ drled over magnesium sulfate,
iQ filtered and concentrated in vacuo to a syrup. Thi~
material is slurried with 25 ml of methyl alcohol and the
red crystals formed are collected by filtration. The pro-
duct is washed with diethyl ether and is dried ln vacuo,
mp 296-298C.




- 31 -

Representative Drawing

Sorry, the representative drawing for patent document number 1098127 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1981-03-24
(22) Filed 1976-08-12
(45) Issued 1981-03-24
Expired 1998-03-24

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1976-08-12
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
AMERICAN CYANAMID COMPANY
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-03-11 1 7
Claims 1994-03-11 8 253
Abstract 1994-03-11 1 11
Cover Page 1994-03-11 1 15
Description 1994-03-11 32 1,298